Related references
Note: Only part of the references are listed.Population Representation in HIV Cure Research: A Review of Diversity Within HIV Cure Studies Based in the United States
Carly Roberts et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2022)
The major genetic risk factor for severe COVID-19 is associated with protection against HIV
Hugo Zeberg
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells
Laura E. P. Huyveneers et al.
VIRUSES-BASEL (2022)
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study
Laura N. Walti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Steven G. Deeks et al.
NATURE MEDICINE (2021)
Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials
Laura Powell et al.
JOURNAL OF CLINICAL VIROLOGY (2021)
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report
Ravindra Kumar Gupta et al.
LANCET HIV (2020)
From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation
Cecilia A. Prator et al.
CURRENT HIV/AIDS REPORTS (2020)
Haemopoietic cell transplantation in patients living with HIV
Richard F. Ambinder et al.
LANCET HIV (2020)
Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease
Sherrie J. Divito et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk
Koen Van Besien et al.
LEUKEMIA & LYMPHOMA (2019)
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Ravindra K. Gupta et al.
NATURE (2019)
CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
Lei Xu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab
Carla Serra-Peinado et al.
NATURE COMMUNICATIONS (2019)
A Simpler and More Sensitive Single-Copy HIV-1 RNA Assay for Quantification of Persistent HIV-1 Viremia in Individuals on Suppressive Antiretroviral Therapy
Melissa A. Tosiano et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
HIV-1 reservoir dynamics in CD4+T cells
Katherine M. Bruner et al.
CURRENT OPINION IN HIV AND AIDS (2019)
The B-Cell Follicle in HIV Infection: Barrier to a Cure
Matthew P. Bronnimann et al.
FRONTIERS IN IMMUNOLOGY (2018)
Transplantation of CCR5Δ32 Homozygous Umbilical Cord Blood in a Child With Acute Lymphoblastic Leukemia and Perinatally Acquired HIV Infection
Meghan Rothenberger et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers
Ute V. Solloch et al.
HUMAN IMMUNOLOGY (2017)
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy
Timothy J. Henrich et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection
Priyanka Uprety et al.
CLINICAL INFECTIOUS DISEASES (2017)
Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT
D. M. Burns et al.
BONE MARROW TRANSPLANTATION (2016)
Stem cell transplantation in strategies for curing HIV/AIDS
Gero Huetter
AIDS RESEARCH AND THERAPY (2016)
8/8 and 10/10 High-Resolution Match Rate for the Be The Match Unrelated Donor Registry
Jason Dehn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants
Priyanka Uprety et al.
CLINICAL INFECTIOUS DISEASES (2015)
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
Amanda M. Crooks et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption
Meghan K. Rothenberger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Changes in HIV reservoirs during long-term antiretroviral therapy
Feiyu F. Hong et al.
CURRENT OPINION IN HIV AND AIDS (2015)
CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report
Rafael F. Duarte et al.
LANCET HIV (2015)
Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation Report of 2 Cases
Timothy J. Henrich et al.
ANNALS OF INTERNAL MEDICINE (2014)
The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation
Ioannis Politikos et al.
BLOOD (2014)
Dependence on the CCR5 Coreceptor for Viral Replication Explains the Lack of Rebound of CXCR4-Predicted HIV Variants in the Berlin Patient
Jori Symons et al.
CLINICAL INFECTIOUS DISEASES (2014)
Immune responses in neonates
Saleem Basha et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Naive T cells, unconventional NK and NKT cells, and highly responsive monocyte-derived macrophages characterize human cord blood
Maria C. Lopez et al.
IMMUNOBIOLOGY (2014)
Improved Single-Copy Assays for Quantification of Persistent HIV-1 Viremia in Patients on Suppressive Antiretroviral Therapy
Anthony R. Cillo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry
Loren Gragert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
More on Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32/Delta32 Mutation
Gero Huetter
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation
Lambros Kordelas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Alison L. Hill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4+ memory T Cells
S. Jaafoura et al.
NATURE COMMUNICATIONS (2014)
Hematopoietic Cell Transplantation with Cord Blood for Cure of HIV Infections
Lawrence D. Petz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Cord Blood Transplantation for Cure of HIV Infections
Lawrence Petz
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Single Cord Blood Transplantation Combined With An HLA Mismatched Third Party Donor For High-Risk Hematological Patients With HIV Infection
Mi Kwon et al.
BLOOD (2013)
Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2
Gero Huetter et al.
AIDS (2011)
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
Kristina Allers et al.
BLOOD (2011)
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions
Hongtao Liu et al.
BLOOD (2011)
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Tae-Wook Chun et al.
AIDS (2010)
Selective increase of activation antigens HLA-DR and CD38 on CD45RO+ T lymphocytes during HIV-1 infection
L. KESTENS et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile Virus infection: A meta-analysis of 4 cohorts in the US epidemic
Jean K. Lim et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Role for CCR5Δ32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells
L Agrawal et al.
JOURNAL OF VIROLOGY (2004)
T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: Implications for HIV pathogenesis
JM Brenchley et al.
JOURNAL OF VIROLOGY (2004)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Unrelated umbilical cord blood transplants in adults:: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor
MN Fernández et al.
EXPERIMENTAL HEMATOLOGY (2003)
HIV preferentially infects HIV-specific CD4+ T cells
DC Douek et al.
NATURE (2002)